Article Information
vol. 11 no. 507
- Received for publication December 19, 2018
- Resubmitted February 25, 2019
- Accepted for publication July 31, 2019
- .
Author Information
- Philip K. Ehrenberg1,*,
- Shida Shangguan1,2,*,
- Biju Issac1,2,
- Galit Alter3,
- Aviva Geretz1,2,
- Taisuke Izumi1,2,
- Christopher Bryant4,
- Michael A. Eller1,2,
- Frank Wegmann5,
- Richard Apps6,
- Matthew Creegan1,2,
- Diane L. Bolton1,2,
- Rafick P. Sekaly7,
- Merlin L. Robb1,2,
- Robert A. Gramzinski1,
- Maria G. Pau5,
- Hanneke Schuitemaker5,
- Dan H. Barouch3,8,
- Nelson L. Michael1,2 and
- Rasmi Thomas1,2,†
- 1U.S. Military HIV Research Program (MHRP), Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.
- 2Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD 20817, USA.
- 3Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.
- 4EMMES Corporation, Rockville, MD 20850, USA.
- 5Janssen Vaccines and Prevention B.V., 2329 Leiden, Netherlands.
- 6Center for Human Immunology, National Institutes of Health, Bethesda, MD 20814, USA.
- 7Case Western Reserve University, Cleveland, OH 44106, USA.
- 8Center for Virology and Vaccine Research, BIDMC, Harvard Medical School, Boston, MA 02115, USA.
- ↵†Corresponding author. Email: rthomas{at}hivresearch.org